• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂代谢紊乱在慢性肾脏病能量代谢障碍、氧化应激、炎症和心血管疾病中的作用。

Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.

机构信息

Division of Nephrology and Hypertension, University of California Irvine Medical Center, Suite 400, City Tower, 101 City Drive, Orange, CA, 92868, USA,

出版信息

Clin Exp Nephrol. 2014 Apr;18(2):265-8. doi: 10.1007/s10157-013-0847-z. Epub 2013 Aug 24.

DOI:10.1007/s10157-013-0847-z
PMID:23974528
Abstract

Advanced chronic kidney disease (CKD) results in a constellation of dysregulation of lipid metabolism, oxidative stress, and inflammation which are causally interconnected and participate in a vicious cycle. The CKD-associated lipid disorders are marked by impaired clearance of very low density lipoprotein and chylomicrons, hypertriglyceridemia, formation of small dense low-density lipoprotein (LDL), oxidative modification of LDL, intermediate density lipoprotein and chylomicron remnants, and high-density lipoprotein deficiency and dysfunction. This review provides a brief overview of the role of CKD-induced lipid disorders in the pathogenesis of oxidative stress, inflammation, cardiovascular disease, impaired exercise capacity, cachexia and wasting syndrome.

摘要

晚期慢性肾脏病(CKD)导致脂质代谢、氧化应激和炎症的失调,这些失调相互因果关联,并形成恶性循环。CKD 相关的脂质异常表现为极低密度脂蛋白和乳糜微粒清除受损、高甘油三酯血症、小而密 LDL 的形成、LDL、中间密度脂蛋白和乳糜微粒残基的氧化修饰以及高密度脂蛋白缺乏和功能障碍。本文简要综述了 CKD 引起的脂质异常在氧化应激、炎症、心血管疾病、运动能力下降、恶病质和消耗综合征发病机制中的作用。

相似文献

1
Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.脂代谢紊乱在慢性肾脏病能量代谢障碍、氧化应激、炎症和心血管疾病中的作用。
Clin Exp Nephrol. 2014 Apr;18(2):265-8. doi: 10.1007/s10157-013-0847-z. Epub 2013 Aug 24.
2
Lipid disorders and their relevance to outcomes in chronic kidney disease.脂质代谢紊乱及其与慢性肾脏病患者预后的相关性。
Blood Purif. 2011;31(1-3):189-96. doi: 10.1159/000321845. Epub 2011 Jan 10.
3
HDL metabolism and activity in chronic kidney disease.慢性肾脏病中的高密度脂蛋白代谢和功能。
Nat Rev Nephrol. 2010 May;6(5):287-96. doi: 10.1038/nrneph.2010.36. Epub 2010 Mar 23.
4
Causes of dysregulation of lipid metabolism in chronic renal failure.慢性肾衰竭中脂质代谢失调的原因。
Semin Dial. 2009 Nov-Dec;22(6):644-51. doi: 10.1111/j.1525-139X.2009.00661.x.
5
Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.脂毒性和慢性肾脏病中高密度脂蛋白介导的胆固醇逆转运受损。
J Ren Nutr. 2010 Sep;20(5 Suppl):S35-43. doi: 10.1053/j.jrn.2010.05.010.
6
Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.尿毒症脂蛋白代谢异常及其对心血管疾病的影响。
Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S14-9. doi: 10.1053/ajkd.2001.27384.
7
The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease.高密度脂蛋白在慢性肾脏病患者中的作用和功能及心血管疾病风险。
Int J Mol Sci. 2020 Jan 17;21(2):601. doi: 10.3390/ijms21020601.
8
Mechanisms of dyslipidemia of chronic renal failure.慢性肾衰竭血脂异常的机制。
Hemodial Int. 2006 Jan;10(1):1-7. doi: 10.1111/j.1542-4758.2006.01168.x.
9
Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations.在终末期肾病患者人群中,降低胆固醇干预措施缺乏有益效果的原因。
Blood Purif. 2013;35(1-3):31-6. doi: 10.1159/000345176. Epub 2013 Jan 22.
10
[Dyslipidemia as a therapeutic target for prevention of cardiovascular events and end-stage renal disease].[血脂异常作为预防心血管事件和终末期肾病的治疗靶点]
Nihon Rinsho. 2008 Sep;66(9):1761-9.

引用本文的文献

1
Association between the triglyceride to high-density lipoprotein cholesterol ratio and diabetes mellitus likelihood in patients with chronic kidney disease.慢性肾病患者甘油三酯与高密度脂蛋白胆固醇比值和糖尿病患病可能性之间的关联
BMC Nephrol. 2025 Aug 19;26(1):470. doi: 10.1186/s12882-025-04377-9.
2
Pemafibrate ameliorates renal injury through induction of FGF21 and ketone body production in male mice.非诺贝特通过诱导雄性小鼠产生成纤维细胞生长因子21和酮体来改善肾损伤。
Physiol Rep. 2025 Feb;13(3):e70135. doi: 10.14814/phy2.70135.
3
Analysis of changes in PCSK9 and TNF-α concentrations in response to physical exercises using virtual reality in patients in the fifth stage of chronic kidney disease undergoing hemodialysis.

本文引用的文献

1
Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production.尿毒症导致肝载脂蛋白 A-I 产生下调的转录后性质。
Transl Res. 2013 Jun;161(6):477-85. doi: 10.1016/j.trsl.2012.11.001. Epub 2012 Dec 3.
2
Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.慢性血液透析患者的功能失调高密度脂蛋白。
J Am Coll Cardiol. 2012 Dec 11;60(23):2372-9. doi: 10.1016/j.jacc.2012.09.013. Epub 2012 Nov 7.
3
Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expression.
对接受血液透析的慢性肾病五期患者使用虚拟现实进行体育锻炼后PCSK9和TNF-α浓度变化的分析。
BMC Nephrol. 2025 Jan 2;26(1):1. doi: 10.1186/s12882-024-03917-z.
4
Effects of Polyphenol-Rich Foods on Lipids and Oxidative Stress Status in Patients with Hyperlipidemia: A Systematic Review of Randomized Controlled Trials.富含多酚的食物对高脂血症患者血脂和氧化应激状态的影响:随机对照试验的系统评价
J Multidiscip Healthc. 2024 Jul 8;17:3167-3179. doi: 10.2147/JMDH.S471372. eCollection 2024.
5
Lipid and nutritional profiles of Caribbean patients with chronic kidney disease.加勒比地区慢性肾脏病患者的血脂和营养状况。
Afr Health Sci. 2023 Sep;23(3):645-654. doi: 10.4314/ahs.v23i3.75.
6
Lipoproteins and Their Effects on the Cardiovascular System.脂蛋白及其对心血管系统的影响。
Cureus. 2023 Nov 15;15(11):e48865. doi: 10.7759/cureus.48865. eCollection 2023 Nov.
7
Relationship of serum lipid parameters with kidney function decline accompanied by systemic arterial stiffness: a retrospective cohort study.血清脂质参数与伴有全身动脉僵硬度的肾功能下降的关系:一项回顾性队列研究。
Clin Kidney J. 2023 May 26;16(11):2289-2298. doi: 10.1093/ckj/sfad131. eCollection 2023 Nov.
8
The Beneficial Effects of Curcumin on Lipids: Possible Effects on Dyslipidemia-induced Cardiovascular Complications.姜黄素对血脂的有益作用:对血脂异常引起的心血管并发症的可能影响。
Curr Med Chem. 2024;31(42):6957-6970. doi: 10.2174/0929867331666230707094644.
9
The prognostic value of monocyte-to-lymphocyte ratio in peritoneal dialysis patients.单核细胞与淋巴细胞比值对腹膜透析患者的预后价值。
Eur J Med Res. 2023 Apr 10;28(1):152. doi: 10.1186/s40001-023-01073-y.
10
Therapeutic Effect of Curcumin on 5/6Nx Hypertriglyceridemia: Association with the Improvement of Renal Mitochondrial β-Oxidation and Lipid Metabolism in Kidney and Liver.姜黄素对5/6肾切除所致高甘油三酯血症的治疗作用:与肾线粒体β-氧化及肾和肝脏脂质代谢改善的关系
Antioxidants (Basel). 2022 Nov 6;11(11):2195. doi: 10.3390/antiox11112195.
慢性肾脏病中的脂蛋白脂肪酶缺乏伴随着内皮细胞 GPIHBP1 表达的下调。
Clin Exp Nephrol. 2012 Apr;16(2):238-43. doi: 10.1007/s10157-011-0549-3. Epub 2011 Oct 19.
4
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.辛伐他汀联合依折麦布降低慢性肾脏病患者 LDL 胆固醇的效果(心脏和肾脏保护研究):一项随机安慰剂对照试验。
Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.
5
Lipid disorders and their relevance to outcomes in chronic kidney disease.脂质代谢紊乱及其与慢性肾脏病患者预后的相关性。
Blood Purif. 2011;31(1-3):189-96. doi: 10.1159/000321845. Epub 2011 Jan 10.
6
New insights into lipid metabolism in chronic kidney disease.慢性肾脏病中脂质代谢的新见解。
J Ren Nutr. 2011 Jan;21(1):120-3. doi: 10.1053/j.jrn.2010.10.017.
7
Atherosclerosis in CKD: differences from the general population.慢性肾脏病患者的动脉粥样硬化:与普通人群的差异。
Nat Rev Nephrol. 2010 Dec;6(12):723-35. doi: 10.1038/nrneph.2010.143. Epub 2010 Oct 26.
8
ApoA-1 mimetic peptide reverses uremia-induced upregulation of pro-atherogenic pathways in the aorta.载脂蛋白 A-1 模拟肽可逆转尿毒症引起的主动脉中促动脉粥样硬化途径的上调。
Am J Nephrol. 2010;32(3):201-211. doi: 10.1159/000316479. Epub 2010 Jul 16.
9
HDL metabolism and activity in chronic kidney disease.慢性肾脏病中的高密度脂蛋白代谢和功能。
Nat Rev Nephrol. 2010 May;6(5):287-96. doi: 10.1038/nrneph.2010.36. Epub 2010 Mar 23.
10
In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.载脂蛋白A-1模拟肽对终末期肾病患者血浆中高密度脂蛋白抗炎活性的体外刺激及低密度脂蛋白促炎活性的抑制作用
Kidney Int. 2009 Aug;76(4):437-44. doi: 10.1038/ki.2009.177. Epub 2009 May 27.